Achilles Therapeutics
(NASDAQ:ACHL)
$0.8874
-0.0312[-3.40%]
At close: May 9
$0.8874
0[0.00%]
PreMarket: 9:15AM EDT
Q1 2024 Earnings were released on Wed May 8th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Achilles Therapeutics Stock (NASDAQ:ACHL), Quotes and News Summary

Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.1.000 / 679.921K
Day Range- - -
52 Wk Range0.740 - 1.760
Market Cap$36.823M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
0.15%
Days to Cover1

Recent News

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03.
Avi Kapoor
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.
Avi Kapoor
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P 500 also rose, gaining, 0.75% to 5,250.72.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACHL
FBIO

FAQ

Q

How do I buy Achilles Therapeutics (ACHL) stock?

A

You can purchase shares of Achilles Therapeutics (NASDAQ: ACHL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Achilles Therapeutics's (ACHL) competitors?

A

Other companies in Achilles Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).

Q

What is the target price for Achilles Therapeutics (ACHL) stock?

A

The latest price target for Achilles Therapeutics (NASDAQ: ACHL) was reported by Piper Sandler on Friday, April 5, 2024. The analyst firm set a price target for 2.00 expecting ACHL to rise to within 12 months (a possible 125.38% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Achilles Therapeutics (ACHL)?

A

The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.8874 last updated May 9, 2024 at 9:15 AM EDT.

Q

Does Achilles Therapeutics (ACHL) pay a dividend?

A

There are no upcoming dividends for Achilles Therapeutics.

Q

When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?

A

Achilles Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.

Q

Is Achilles Therapeutics (ACHL) going to split?

A

There is no upcoming split for Achilles Therapeutics.

Q

What sector and industry does Achilles Therapeutics (ACHL) operate in?

A

Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch